We are live on ! Find out more
ATI

Act Two Investors Portfolio holdings

AUM $453M
1-Year Est. Return 10.9%
This Fund
S&P 500
This Quarter Est. Return
+12.51%
1 Year Est. Return
+10.9%
3 Year Est. Return
+52.85%
5 Year Est. Return
+67.7%
10 Year Est. Return
AUM
$463M
AUM Growth
+$89.2M
Cap. Flow
+$41.9M
Cap. Flow %
9.05%
Top 10 Hldgs %
68.86%
Holding
50
New
14
Increased
28
Reduced
3
Closed
3

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$8.51M
2
ENB icon
Enbridge
ENB
+$7.25M
3
V icon
Visa
V
+$5.92M
4
BND icon
Vanguard Total Bond Market
BND
+$4.18M
5
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$3.42M

Sector Composition

Rank Sector Weight
1 Technology 24.04%
2 Communication Services 19.34%
3 Financials 12.92%
4 Healthcare 10.66%
5 Consumer Discretionary 6.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.45T
$56.8M 12.26%
150,937
+9,455
+7% +$3.37M
GOOG icon
2
Alphabet (Google) Class C
GOOG
$4.36T
$43.2M 9.32%
306,210
+971
+0.3% +$132K
NXPI icon
3
NXP Semiconductors
NXPI
$57.8B
$34.7M 7.5%
151,136
+5,482
+4% +$1.1M
TMUS icon
4
T-Mobile US
TMUS
$185B
$33.1M 7.15%
206,544
+14,446
+8% +$2.14M
UNH icon
5
UnitedHealth
UNH
$376B
$29.9M 6.46%
56,768
+2,609
+5% +$1.39M
AMZN icon
6
Amazon
AMZN
$2.92T
$29.2M 6.3%
191,958
+2,156
+1% +$302K
V icon
7
Visa
V
$684B
$25.5M 5.52%
98,077
+24,033
+32% +$5.92M
NOC icon
8
Northrop Grumman
NOC
$77.1B
$24M 5.18%
51,194
+1,168
+2% +$547K
VGLT icon
9
Vanguard Long-Term Treasury ETF
VGLT
$10B
$23.8M 5.15%
387,380
+28,618
+8% +$1.62M
AAPL icon
10
Apple
AAPL
$4.54T
$18.7M 4.04%
97,097
+6,445
+7% +$1.19M
SCHW
11
Charles Schwab
SCHW
$183B
$18.1M 3.92%
263,586
+14,106
+6% +$815K
SYY icon
12
Sysco
SYY
$40.8B
$18M 3.88%
245,682
+26,842
+12% +$1.85M
BND icon
13
Vanguard Total Bond Market
BND
$157B
$15.4M 3.32%
208,816
+59,189
+40% +$4.18M
IEF icon
14
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
$15.2M 3.29%
158,146
+37,009
+31% +$3.42M
VZ icon
15
Verizon
VZ
$195B
$9.39M 2.03%
249,042
+240,499
+2,815% +$8.51M
ENB icon
16
Enbridge
ENB
$119B
$8M 1.73%
222,111
+214,871
+2,968% +$7.25M
BX icon
17
Blackstone
BX
$102B
$6.73M 1.45%
51,368
+2,416
+5% +$261K
SCHO icon
18
Schwab Short-Term US Treasury ETF
SCHO
$12.8B
$5.78M 1.25%
238,418
+40,492
+20% +$972K
SYK icon
19
Stryker
SYK
$125B
$5.3M 1.14%
17,684
+532
+3% +$149K
JPM icon
20
JPMorgan Chase
JPM
$935B
$4.82M 1.04%
28,332
+559
+2% +$84.7K
GEHC icon
21
GE HealthCare
GEHC
$30.7B
$4.52M 0.98%
58,474
-11,750
-17% -$823K
CNI icon
22
Canadian National Railway
CNI
$76.9B
$4.15M 0.9%
33,020
TMO icon
23
Thermo Fisher Scientific
TMO
$213B
$4.06M 0.88%
7,650
-21,309
-74% -$10.3M
MCK icon
24
McKesson
MCK
$100B
$3.74M 0.81%
8,073
+178
+2% +$80.9K
CP icon
25
Canadian Pacific Kansas City
CP
$78.1B
$3.32M 0.72%
41,980
+3,995
+11% +$292K

Similar funds

Act Two Investors's Q4 2023 Portfolio in Review

As of Q4 2023, Act Two Investors held 50 positions worth $463M, up 24% from $374M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Act Two Investors deployed $41.9M of net new capital in Q4 2023, opening 14 new positions and adding to 28 existing holdings. Its largest new stake was Johnson & Johnson: 11,790 shares worth $1.85M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $10.3M trimmed.

  • Act Two Investors's largest Q4 2023 buy was Johnson & Johnson: 11,790 shares worth $1.85M.
  • Act Two Investors added most to Verizon in Q4 2023, an estimated $8.51M increase.
  • Act Two Investors's biggest Q4 2023 reduction was Thermo Fisher Scientific, cutting an estimated $10.3M.
  • Act Two Investors fully exited State Street Health Care Select Sector SPDR ETF in Q4 2023, selling an estimated $750K.
  • Act Two Investors's ten largest holdings make up 69% of its $463M portfolio in Q4 2023.
  • Act Two Investors opened 14 new positions and closed 3 in Q4 2023.
  • Act Two Investors's portfolio value rose 24% quarter-over-quarter to $463M.

Based on Act Two Investors's 13F filing for Q4 2023, filed 12 Feb 2024.